Ren and colleagues report that, in these allogeneic cells, there is upregulation of the activating receptor NKG2D, which also engages with ligands expressed on leukemia cells to enhance chimeric antigen receptor (CAR)–instigated killing. Here, KLRK1 is linked to leukemia.